QVA149 reduces the risk of moderate-to-severe exacerbations compared with open-label tiotropium in patients with severe COPD: The SPARK study
EUROPEAN RESPIRATORY JOURNAL（2014）
关键词
Bronchodilators,COPD - management,Treatments
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要